Medicon Valley Alliance R&D Network
June 18 @ 11:00 - 12:15
Welcome to the first webinar for the Medicon Valley Alliance R&D Network!
Connecting the R&D of auto-immune disease therapies – starting from the type 1 diabetes perspective
Over a long period of time, the Øresund region has built up strong and internationally recognised competencies within the fields of screening, genetics and immunology in type 1 diabetes and other autoimmune diseases. The coupling between type 1 diabetes and other autoimmune diseases contains an immense potential for the development of new drugs and therapies. This meeting will give an insight in some of the coordinating and individual R&D efforts that are existing in Medicon Valley today in the field of type 1 diabetes and the bridges to other auto-immune diseases.
Until we can meet in large groups, we have decided to bring the possibility to share experiences in a shorter webinar format instead of our regular networking meetings.
Date: 18 June, 2020
Host: MVA R&D Network
Venue: Online – all registered participants will receive a link 2 days before the event
The MVA R&D Network
The Medicon Valley Alliance R&D Network is a professional and social network for C-level R&D executives (CSOs, CMOs, VPs), university professors and PIs, and top-level managers in the hospital sector. The network focuses on sharing best practice and experiences, as well as discussing current challenges for industry-academia collaboration and the commercialization of R&D in the Medicon Valley region, such as how we can strengthen collaboration and knowledge-sharing between academia and industry to stimulate start-up, scale-up, commercialization and growth and what is required to turn great science into successful innovations.
Joining the network is free of charge but is limited to Medicon Valley Alliance members. However, non-member organizations and companies are welcome to attend one network event to evaluate if joining the network is relevant. If so, becoming a member of Medicon Valley Alliance will automatically allow you to join the medtech network.
Moderator: Sophie Labrosse, Medicon Valley Alliance
10.50-11.00 Webinar platform open for connecting participants
11.00-11.05 Welcome by Petter Hartman, CEO, Medicon Valley Alliance
11.05-11.20 Joining forces for novel treatments for type 1 diabetes
Finn Kristensen, Project Manager DiaUnion, Medicon Valley Alliance
11.20-11.35 Steno Diabetes Centres – a Danish Public Private Partnership
Jannik Hilsted, SVP Patient Care and Chief Medical Officer, Novo Nordisk Fonden
11:35-11:50 Dissecting the etiology of type 1 diabetes and associated celiac and thyroid diseases
Åke Lernmark, Senior Professor and Principal Investigator, Diabetes and Celiac Unit at Lund University
11.50-12.00 The state of R&D in Medicon Valley – 2 pitches
Adam Steensberg, EVP R&D and Chief Medical Officer, Zealand Pharma
Jan Alenfall, CEO, Follicum
Jeannette Söderberg, Associate Director European Research, JDRF
12.10-12.15 Final Q&A and conclusions
Deadline for registration is June 15, 2020 at noon.
For more information please contact Sophie Labrosse at email@example.com